Shih JY - Search Results

1

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

Gautschi O, Milia J, Filleron T, Wolf J, Carbone DP, Owen D, Camidge R, Narayanan V, Doebele RC, Besse B, Remon-Masip J, Janne PA, Awad MM, Peled N, Byoung CC, Karp DD, Van Den Heuvel M, Wakelee HA, Neal JW, Mok TSK, Yang JCH, Ou SI, Pall G, Froesch P, Zalcman G, Gandara DR, Riess JW, Velcheti V, Zeidler K, Diebold J, Früh M, Michels S, Monnet I, Popat S, Rosell R, Karachaliou N, Rothschild SI, Shih JY, Warth A, Muley T, Cabillic F, Mazières J, Drilon A. Gautschi O, et al. Among authors: shih jy. J Clin Oncol. 2017 May 1;35(13):1403-1410. doi: 10.1200/JCO.2016.70.9352. Epub 2017 Mar 13. J Clin Oncol. 2017. PMID: 28447912 Free PMC article.

2

Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.

Yang CH, Yu CJ, Shih JY, Chang YC, Hu FC, Tsai MC, Chen KY, Lin ZZ, Huang CJ, Shun CT, Huang CL, Bean J, Cheng AL, Pao W, Yang PC. Yang CH, et al. Among authors: shih jy. J Clin Oncol. 2008 Jun 1;26(16):2745-53. doi: 10.1200/JCO.2007.15.6695. J Clin Oncol. 2008. PMID: 18509184 Clinical Trial.

3

Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors.

Lin CC, Hsu HH, Sun CT, Shih JY, Lin ZZ, Yu CJ, Chen GG, Hsin MK, Lam KC, Leung L, Yang CH, Mok T. Lin CC, et al. Among authors: shih jy. J Thorac Oncol. 2010 Sep;5(9):1424-9. doi: 10.1097/JTO.0b013e3181e9db73. J Thorac Oncol. 2010. PMID: 20631634 Free article.

4

Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.

Yuan S, Yu SL, Chen HY, Hsu YC, Su KY, Chen HW, Chen CY, Yu CJ, Shih JY, Chang YL, Cheng CL, Hsu CP, Hsia JY, Lin CY, Wu G, Liu CH, Wang CD, Yang KC, Chen YW, Lai YL, Hsu CC, Lin TC, Yang TY, Chen KC, Hsu KH, Chen JJ, Chang GC, Li KC, Yang PC. Yuan S, et al. Among authors: shih jy. J Clin Oncol. 2011 Sep 1;29(25):3435-42. doi: 10.1200/JCO.2011.35.3979. Epub 2011 Aug 1. J Clin Oncol. 2011. PMID: 21810691

5

Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

Su KY, Chen HY, Li KC, Kuo ML, Yang JC, Chan WK, Ho BC, Chang GC, Shih JY, Yu SL, Yang PC. Su KY, et al. Among authors: shih jy. J Clin Oncol. 2012 Feb 1;30(4):433-40. doi: 10.1200/JCO.2011.38.3224. Epub 2012 Jan 3. J Clin Oncol. 2012. PMID: 22215752

6

Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension.

Lin MW, Wu CT, Shih JY, Chang YL, Yang PC. Lin MW, et al. Among authors: shih jy. J Surg Oncol. 2014 Aug;110(2):99-106. doi: 10.1002/jso.23628. Epub 2014 Apr 30. J Surg Oncol. 2014. PMID: 24788590

7

Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer.

Lin YT, Wang YF, Yang JC, Yu CJ, Wu SG, Shih JY, Yang PC. Lin YT, et al. Among authors: shih jy. J Thorac Oncol. 2014 Nov;9(11):1720-5. doi: 10.1097/JTO.0000000000000326. J Thorac Oncol. 2014. PMID: 25436806 Free article.

8

Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.

Tsai TH, Wu SG, Hsieh MS, Yu CJ, Yang JC, Shih JY. Tsai TH, et al. Among authors: shih jy. Lung Cancer. 2015 May;88(2):208-14. doi: 10.1016/j.lungcan.2015.02.018. Epub 2015 Mar 4. Lung Cancer. 2015. PMID: 25773866

9

Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene.

Wu H, Shih JY, Yang JC. Wu H, et al. Among authors: shih jy. J Thorac Oncol. 2015 Sep;10(9):e95-e96. doi: 10.1097/JTO.0000000000000611. J Thorac Oncol. 2015. PMID: 26291023 Free article. No abstract available.

10

Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis.

Chen LY, Molina-Vila MA, Ruan SY, Su KY, Liao WY, Yu KL, Ho CC, Shih JY, Yu CJ, Yang JC, Rosell R, Yang PC. Chen LY, et al. Among authors: shih jy. Lung Cancer. 2016 Apr;94:46-53. doi: 10.1016/j.lungcan.2016.01.019. Epub 2016 Jan 30. Lung Cancer. 2016. PMID: 26973206 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

340 results

Search Page